News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,823 Results
Type
Article (14015)
Company Profile (304)
Press Release (248504)
Section
Business (79402)
Career Advice (152)
Deals (13205)
Drug Delivery (34)
Drug Development (50359)
Employer Resources (31)
FDA (5691)
Job Trends (5120)
News (144205)
Policy (10018)
Tag
Academia (901)
Alliances (21576)
Alzheimer's disease (777)
Antibody-drug conjugate (ADC) (64)
Approvals (5679)
Artificial intelligence (80)
Bankruptcy (99)
Best Places to Work (4539)
Biotechnology (249)
Breast cancer (121)
Cancer (998)
Cardiovascular disease (83)
Career advice (132)
CAR-T (82)
Cell therapy (239)
Clinical research (40320)
Collaboration (371)
Compensation (152)
COVID-19 (1013)
C-suite (99)
Cystic fibrosis (69)
Data (1045)
Diabetes (92)
Diagnostics (1214)
Earnings (29047)
Events (47377)
Executive appointments (296)
FDA (6115)
Funding (358)
Gene editing (70)
Gene therapy (179)
GLP-1 (325)
Government (1065)
Healthcare (6559)
Infectious disease (1054)
Inflammatory bowel disease (100)
IPO (7216)
Job creations (859)
Job search strategy (127)
Layoffs (191)
Legal (1376)
Lung cancer (146)
Lymphoma (63)
Manufacturing (91)
Medical device (2563)
Medtech (2564)
Mergers & acquisitions (6169)
Metabolic disorders (283)
Neuroscience (1055)
NextGen: Class of 2025 (2013)
Non-profit (850)
Northern California (1196)
Obesity (154)
Opinion (93)
Parkinson's disease (82)
Patents (68)
People (25214)
Phase I (14225)
Phase II (18745)
Phase III (11867)
Pipeline (446)
Postmarket research (851)
Preclinical (5979)
Radiopharmaceuticals (207)
Rare diseases (219)
Real estate (1411)
Regulatory (8348)
Research institute (933)
Series A (71)
Southern California (1074)
Startups (1967)
United States (9467)
Vaccines (174)
Weight loss (91)
Date
Today (19)
Last 7 days (207)
Last 30 days (1112)
Last 365 days (20407)
2025 (975)
2024 (20574)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23357)
2019 (16224)
2018 (11740)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (17012)
Australia (2871)
California (2722)
Canada (867)
China (247)
Colorado (101)
Connecticut (116)
Europe (36591)
Florida (303)
Georgia (78)
Illinois (169)
Indiana (66)
Maryland (361)
Massachusetts (2164)
Minnesota (111)
New Jersey (672)
New York (747)
North Carolina (441)
Northern California (1196)
Ohio (87)
Pennsylvania (520)
South America (207)
Southern California (1074)
Texas (304)
Washington State (266)
262,823 Results for "aligos therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aligos Therapeutics to Present at Investor Conferences in December
November 26, 2024
·
2 min read
MASH
Aligos Claims Mid-Stage Win in MASH but Investors Are Skeptical
An unusual placebo effect in Aligos Therapeutics’ Phase IIa trial is driving shareholder skepticism for its metabolic dysfunction-associated steatohepatitis candidate, according to Jefferies analyst Michael Yee.
September 20, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
November 19, 2024
·
7 min read
Biotech Bay
Aligos Therapeutics Presents Positive Data at the EASL Congress 2024
Aligos Therapeutics, Inc. announced positive data from six poster presentations at the European Association for the Study of the Liver Congress 2024, being held June 5-8 in Milan, Italy.
June 5, 2024
·
5 min read
Press Releases
Aligos Therapeutics to Present at Investor Conferences in October
September 30, 2024
·
2 min read
Press Releases
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024
December 16, 2024
·
3 min read
Business
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
Aligos Therapeutics, Inc. reported recent business progress and financial results for the first quarter 2024.
May 7, 2024
·
9 min read
Press Releases
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
November 7, 2024
·
9 min read
Biotech Bay
Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024
Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”) today announced that management will participate in one-on-one meetings at the Piper Sandler Spring Biopharma Symposium 2024 being held in Boston, Massachusetts on April 16-17, 2024.
April 9, 2024
·
1 min read
Biotech Bay
Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024
Aligos Therapeutics, Inc. today announced six abstracts have been accepted for poster presentations, including two Top abstracts, at the European Association for the Study of the Liver (EASL) Congress 2024, being held June 5-8 in Milan, Italy.
May 22, 2024
·
4 min read
1 of 26,283
Next
